Ingevity Corp (NGVT)
🔔 Watch stock
Stock Watch
Stock Watch will tell you what changes at Ingevity Corp.
Later $1 a month per stock — signing up is free, and you'll be the first to know when it launches.
Trading Day
Key levels of the most recently completed trading day — not a live quote.
52-Week Range
Current price 73.10 $ — 87% of the range above the low.
Lowest and highest closing price over the last 52 weeks. The marker shows where the current price sits within that range: close to the high speaks for strength, close to the low for weakness.
Basics
Performance
Technical Indicators
Calculated from the price history · as of 08/03/2026
Valuation
Profitability
Balance Sheet & Safety
Growth
Dividend
This stock currently pays no dividend.
Quality & Screener
AI Rating
–Not yet rated — we only show a category once an SEC-backed file with at least two cited passages is available. How the Rating Is Built
Growth Score
4 of 10 Weak growthTen checks against the annual reports — each one passed counts a point.
- Revenue grows by more than 15% a year over three years -11.2% failed
- More than 10% revenue growth is expected for the coming year -2.1% failed
- Share count grows by less than 3% a year -2.0% passed
- Revenue growth plus cash-flow margin add up to at least 40 ("Rule of 40") 6.4% failed
- Gross margin at 40% or higher and without meaningful erosion 39.5% failed
- Goodwill from acquisitions does not grow faster than revenue 0.3% passed
- Net debt below twice EBITDA 31.1 x EBITDA failed
- Operating cash flow covers the profits of the last three years 1,268 m passed
- Return on capital at 15% or higher, or up versus two years ago 20.0% passed
- Insiders hold at least 10% or are net buyers 0.8% failed
A criterion without figures counts neither as passed nor as failed; a score is only produced from 7 judgeable criteria upwards. Source: fundamental data. All ten criteria in detail
Highlighted are things our editorial team noticed: green = stands out as strong, red = deserves a closer look. No single metric is a verdict on its own — always read it in context.
Analysts & Price Target
The price target sits 21.8% above the current price.
- Consensus
- Sell
- Analyst Ratings
- 4
Combined picture of the price targets and recommendations of every analyst covering the stock. Price targets are expectations for the next 12 months, not promises — and they often follow the price rather than predict it.
Estimates by Fiscal Year
| Fiscal Year | EPS Estimate ($) | EPS Range ($) | Revenue Estimate ($M) | Expected Growth | Analysts |
|---|---|---|---|---|---|
| 12/31/2026 | 5.24 | 5.05 – 5.53 | 1,110 | 15.2% | 3 |
| 12/31/2027 | 6.01 | 5.80 – 6.19 | 1,130 | 14.7% | 3 |
Average of the analyst estimates for the coming fiscal years. The range shows how far the most optimistic and the most cautious estimate sit apart — the wider it is, the less certain the expectation.
Next Reporting Date
Expected date of the next quarterly or annual figures. Dates do shift occasionally — only the invitation issued by the company is binding.
Revenue & Profit
Cash Flow
Balance Sheet
Margins
Per Share
Click the chart or tab into it, then use ← and → to step through the periods.
None of the selected stocks reports this metric. Pick another metric or switch between annual and quarterly.
· Total · per year
These companies report in different currencies — switch on “Indexed” or pick a margin for a fair comparison.
The figures could not be loaded right now.
Source: fundamental data
Quarterly Figures
| Quarter | EPS (Earnings Per Share) | EPS YoY (%) | Sales ($M) | Sales YoY (%) | Net Margin (%) | OCF ($M) | FCF ($M) |
|---|---|---|---|---|---|---|---|
| 2024: Q4 | 0.45 | – | 299 | -19.60 | 5.60 | 65 | 40 |
| 2025: Q1 | 0.56 | – | 248 | -27.10 | 8.30 | 25 | 15 |
| 2025: Q2 | -4.02 | – | 332 | -15.10 | -44.20 | 79 | 67 |
| 2025: Q3 | 1.18 | – | 333 | -11.60 | 13.10 | 130 | 118 |
| 2025: Q4 | -2.37 | -622.50 | 255 | -14.60 | -33.20 | 97 | 74 |
| 2026: Q1 | 1.66 | 197.10 | 258 | 4.10 | 23.20 | -2 | -12 |
| 2026: Q2 | 1.00 | 124.90 | 314 | -5.20 | 11.20 | -14 | -14 |
- EPS (Earnings Per Share):
- Quarterly profit divided by the total share count — how much of the profit works out to a single share.
- YoY (Year over Year):
- Change versus the same quarter a year ago — this is how you compare without seasonal distortion (e.g. the holiday shopping season).
- Sales:
- All revenue for the quarter, before any costs are deducted — the top line of the income statement.
- Net Margin:
- What percentage of sales is left over as profit in the end. Negative means the company is posting a loss.
- OCF (Operating Cash Flow):
- The cash that actually flows into the till from the core business during the quarter — harder to dress up than book profit.
- FCF (Free Cash Flow):
- Operating cash flow minus capital expenditures — the money that's genuinely free to use, say for paying down debt, buybacks, or dividends.
Annual Figures
| Fiscal Year | Revenue ($M) | EBIT ($M) | Net Income ($M) | EPS ($) | Operating Cash Flow ($M) | Equity ($M) | Total Assets ($M) |
|---|---|---|---|---|---|---|---|
| 2016 | 908 | 160 | 35 | 0.83 | 128 | 135 | 833 |
| 2017 | 972 | 203 | 126 | 2.97 | 174 | 278 | 930 |
| 2018 | 1,134 | 263 | 169 | 3.97 | 252 | 340 | 1,315 |
| 2019 | 1,293 | 328 | 184 | 4.35 | 276 | 531 | 2,144 |
| 2020 | 1,216 | 298 | 181 | 4.37 | 352 | 647 | 2,335 |
| 2021 | 1,392 | 307 | 118 | 2.95 | 293 | 674 | 2,469 |
| 2022 | 1,668 | 341 | 212 | 5.50 | 313 | 698 | 2,737 |
| 2023 | 1,692 | 256 | -5 | -0.15 | 205 | 631 | 2,623 |
| 2024 | 1,406 | 260 | -430 | -11.85 | 129 | 195 | 2,023 |
| 2025 | 1,168 | 262 | -167 | -4.62 | 331 | 30 | 1,651 |
Fiscal years from the audited annual reports, oldest first. EBIT is the operating profit before interest and taxes; total assets are everything the company owns.
About the Company
Ingevity Corporation fertigt und verkauft Aktivkohleprodukte, abgeleitete Spezialchemikalien und technische Polymere in Nordamerika, im asiatisch-pazifischen Raum, Europa, dem Nahen Osten, Afrika und Südamerika. Sie ist in drei Segmenten tätig: Performance Materials, Performance Chemicals,…
| Employees | 1,400 |
|---|---|
| Headquarters | North Charleston, SC |
| Address | 4920 O'Hear Avenue, 29405 North Charleston, United States |
| Phone | 843 740 2300 |
| Website | ingevity.com |
| IPO Date | 2. May 2016 |
| ISIN | US45688C1071 |
Management
| Name | Title | Birth Year |
|---|---|---|
| David H. Li | President, CEO & Director | 1973 |
| Ryan C. Fisher | Senior VP, General Counsel & Secretary | 1976 |
| Terrance M. Dyer | Senior VP & Chief Human Resources Officer | 1967 |
| Phillip John Platt | Senior VP & CFO | 1981 |
| Reid Clontz | Senior Vice President of Operations | 1974 |
| Ryan Cotterman | Vice President, Chief Accounting Officer & Principal Accounting Officer | 1982 |
| Michael H. Walsh | Vice President of Investor Relations | – |
| Caroline Monahan | Director of Communications | – |
| Michael N. Shukov | Senior VP & President of Advanced Polymer Technologies | 1969 |
| Ruth Castillo | Senior VP & President of Performance Materials | 1978 |
Executives per the latest required filings; titles kept in their original language. Source: fundamental data.
Insider Transactions
| Date | Person | Role | Type | Shares | Price | Value |
|---|---|---|---|---|---|---|
| 24. Jul 2026 | Platt Phillip John | SVP, Chief Financial Officer | Other | 3,294 | 73.26 | 241,318 |
| 6. Jul 2026 | Fisher Ryan C. | SVP, Gen. Counsel & Secretary | Other | 168 | 73.86 | 12,408 |
Reportable transactions by officers and major shareholders from SEC Form 4 filings. "Other" includes things like stock grants and option exercises without a buy/sell character.
View all insider transactions →Chart
Interactive price chart (TradingView).
Data as of: July 31, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.